Endometriosis and Angiogenic Factors

P. G.; Pedro J Grases G; M. Ruggiero; María Ruggiero; Francesca Papini; F. Papini; G. Simi; Vito Cela; V. Cela; Alvarez Zamora R; A. R.

doi:10.5772/29121

Endometriosis and Angiogenic Factors

P. G., Pedro J Grases G, M. Ruggiero, María Ruggiero, Francesca Papini, F. Papini, G. Simi, Vito Cela, V. Cela, Alvarez Zamora R, A. R.

Endometriosis - Basic Concepts and Current Research Trends · 2012 · doi:10.5772/29121 · W1486805211

Review OA: hybrid CC0 ⤵ 4 in-corpus citations

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

Endometriotic implants require neovascularization for establishment and maintenance, driven by interactions between ectopic endometrium and peritoneal tissue.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The development of new blood vessels represents a crucial step during the establishment of endometriosis because endometriotic implants require neovascularization to guarantee oxygen and essential nutrient supply (Groothuis et al., 2005; McLaren, 2000). The interaction between the ectopic endometrium and the peritoneal tissue is a prerequisite for the induction of angiogenesis and the maintenance of endometriosis

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (100)

Cited by (4)

Source provenance

crossref: last seen: 2026-08-31T06:24:59.850064+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] Abnormal interleukin-1 receptor type II gene expression in the endometrium of women with endometriosis via openalex

[2] Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis via openalex

[3] Adverse effects on sperm movement characteristics in women with minimal and mild endometriosis via openalex

[4] Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues via openalex

[5] A modified baboon model for endometriosis via openalex

[6] Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis via openalex

[7] Angiogenesis and its control in the female reproductive system via openalex

[8] Association of polymorphisms of the MMP-2 and TIMP-2 genes with the risk of endometriosis in North Chinese women via openalex

[9] Augmented cell survival in eutopic endometrium from women with endometriosis: expression of c-myc, TGF-beta1 and bax genes via openalex

[10] Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis via openalex

[11] Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells via openalex

[12] Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis via openalex

[13] Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis via openalex

[14] Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture. The Groupe d'Investigation en Gynécologie via openalex

[15] Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis via openalex

[16] Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium via openalex

[17] Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility via openalex

[18] Early endometriosis invades the extracellular matrix via openalex

[19] Early endometriosis invades the extracellular matrix via openalex

[20] Effect of GnRH II and GnRH I on secretion of VEGF by eutopic and ectopic endometrial stromal cells of endometriosis patients via openalex

[21] Effect of interleukin-1 on gamete interaction and mouse embryo development via openalex

[22] Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells via openalex

[23] Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis via openalex

[24] Endometrial-peritoneal interactions during endometriotic lesion establishment via openalex

[25] Endometriosis and infertility: raised iron concentration in the peritoneal fluid and its effect on the acrosome reaction via openalex

[26] Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis via openalex

[27] Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells via openalex

[28] Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9 via openalex

[29] Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis via openalex

[30] Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis via openalex

[31] Expression of transforming growth factor beta1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants via openalex

[32] [Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium] via openalex

[33] Extracellular matrix metalloproteinase inducer expression in the baboon endometrium: menstrual cycle and endometriosis via openalex

[34] Further studies on experimental endometriosis via openalex

[35] Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis via openalex

[36] Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression via openalex

[37] Genetics of endometriosis via openalex

[38] Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis via openalex

[39] High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata via openalex

[40] IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis via openalex

[41] Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata via openalex

[42] Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis via openalex

[43] Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex

[44] Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta via openalex

[45] Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis via openalex

[46] Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin via openalex

[47] Interleukin-1: a possible role in the infertility associated with endometriosis via openalex

[48] Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells via openalex

[49] Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor via openalex

[50] Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin via openalex

[51] Local activation of TGF-beta1 at endometriosis sites via openalex

[52] Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis via openalex

[53] Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis via openalex

[54] Matrix metalloproteinases are elevated in the urine of patients with endometriosis via openalex

[55] Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium via openalex

[56] Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation via openalex

[57] Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 via openalex

[58] Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex

[59] Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis via openalex

[60] Peritoneal fluid cytokines and the relationship with endometriosis and pain via openalex

[61] Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease via openalex

[62] Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis via openalex

[63] Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis via openalex

[64] Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis via openalex

[65] Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis via openalex

[66] Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex

[67] Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model via openalex

[68] Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins via openalex

[69] Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro via openalex

[70] Role of cytokines in endometriosis via openalex

[71] Role of cytokines in endometriosis-associated infertility via openalex

[72] Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids via openalex

[73] Sperm phagocytosis by human peritoneal macrophages: a possible cause of infertility in endometriosis via openalex

[74] Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice via openalex

[75] The effect of peritoneal fluid from patients with endometriosis on human sperm function in vitro via openalex

[76] The effect of peritoneal fluid from patients with endometriosis on human sperm function in vitro via openalex

[77] The influence of peritoneal fluid from patients with minimal stage or treated endometriosis on sperm motility parameters using computer-assisted semen analysis via openalex

[78] The peritoneal fluid levels of interleukin-12 in women with endometriosis via openalex

[79] The staging of peritoneal endometriosis by the type of active lesion in addition to the revised American Fertility Society classification via openalex

[80] The vascular endothelial growth factor +405G>C polymorphism in endometriosis via openalex

[81] Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression via openalex

[82] Tumor Necrosis Factor- Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein Expression via openalex

[83] Up-regulation of endocrine gland-derived vascular endothelial growth factor but not vascular endothelial growth factor in human ectopic endometriotic tissue via openalex

[84] Vascular development in endometriosis via openalex

[85] Vascular endothelial growth factor and endometriotic angiogenesis via openalex

[86] Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors via openalex

[87] Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids via openalex

[88] W2053212420 via openalex

[89] W2052734866 via openalex

[90] W2051978298 via openalex

[91] W2089002446 via openalex

[92] W2090025110 via openalex

[93] W2091557419 via openalex

[94] W2095498651 via openalex

[95] W2096190665 via openalex

[96] W2100258830 via openalex

[97] W2044069347 via openalex

[98] W2102156468 via openalex

[99] W2042642675 via openalex

[100] W2036430467 via openalex